Miromatrix Medical Investor Relations Material

Miromatrix Medical Inc. is a biotechnology company focused on developing bioengineered organs and tissues for transplantation. The company uses its proprietary technology to create fully transplantable human organs, such as livers and kidneys, by repopulating decellularized animal organs with human cells. Miromatrix aims to address the global shortage of donor organs by providing alternative, lab-grown solutions for patients in need of transplants. The company's bioengineering platform is designed to produce organs that could potentially eliminate the need for immunosuppressive drugs post-transplant. The company is headquartered in Eden Prairie, Minnesota, and its shares are listed on the NASDAQ.